Overview
Phenylephrine is an alpha-1 adrenergic receptor agonist used to treat hypotension, dilate the pupil, and induce local vasoconstriction. The action of phenylephrine, or neo-synephrine, was first described in literature in the 1930s. Phenylephrine was granted FDA approval in 1939.
Indication
Phenylephrine is available in various drug formulations, which have different indications. Phenylephrine injections are indicated to treat hypotension caused by shock or anesthesia. The ophthalmic formulation is indicated to induce mydriasis and conjunctival vasoconstriction. The intranasal formulation is used to treat congestion, and a topical formulation is used to treat hemorrhoids. Off-label uses include priapism and induction of local vasoconstriction.
Associated Conditions
- Allergic Conjunctivitis (AC)
- Allergic Rhinitis (AR)
- Allergy to Tree Pollen
- Anorectal discomfort
- Cold
- Common Cold
- Congestion of the Conjunctivas
- Cough
- Cough caused by Common Cold
- Eye allergy
- Eye redness
- Fever
- Flu caused by Influenza
- Haemorrhoids
- Headache
- Headache caused by Allergies
- Headache caused by Common Cold
- Headache caused by Pollen Allergy
- Hypotension
- Irritative cough
- Itching of the nose
- Itching of the throat
- Laryngotracheitis
- Nasal Congestion
- Nose discomfort
- Ocular Inflammation
- Ocular Irritation
- Paroxysmal Supraventricular Tachycardia (PSVT)
- Respiratory tract congestion
- Respiratory tract irritation
- Rhinopharyngitis
- Rhinorrhoea
- Seasonal Allergies
- Sinus Congestion
- Sinus pressure
- Sinusitis
- Sneezing
- Sore Throat
- Tracheobronchitis
- Upper respiratory tract hypersensitivity reaction, site unspecified
- Vasomotor Rhinitis
- Aching caused by Flu caused by Influenza
- Bronchial congestion
- Cold or flu syndrome
- Itchy throat
- Minor aches and pains
- Vascular failure
- Watery itchy eyes
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2025/02/20 | Not Applicable | Recruiting | |||
2025/01/31 | Phase 4 | Recruiting | |||
2025/01/13 | Phase 3 | Not yet recruiting | |||
2024/12/19 | N/A | Active, not recruiting | Centre of Postgraduate Medical Education | ||
2024/10/18 | Phase 3 | Not yet recruiting | |||
2024/07/18 | Not Applicable | Not yet recruiting | General Hospital of Ningxia Medical University | ||
2024/04/19 | N/A | Completed | Catharina Ziekenhuis Eindhoven | ||
2024/02/29 | Not Applicable | Suspended | Samuel Lunenfeld Research Institute, Mount Sinai Hospital | ||
2024/02/08 | Phase 4 | Recruiting | Hassan II University | ||
2024/01/24 | N/A | Recruiting |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| Armas Pharmaceuticals Inc. | 72485-506 | INTRAVENOUS | 100 mg in 10 mL | 6/1/2021 | |
| Lifestar Pharma LLC | 70756-623 | INTRAVENOUS | 100 mg in 10 mL | 3/29/2023 | |
| Sandoz Inc | 0781-3422 | INTRAVENOUS | 10 mg in 1 mL | 10/17/2022 | |
| Walgreen Company | 0363-8005 | ORAL | 10 mg in 20 mL | 4/25/2025 | |
| Jiangxi Hemei Pharmaceutical Co., Ltd | 84010-121 | TOPICAL | 0.25 g in 100 g | 5/23/2025 | |
| Publix Super Markets Inc | 56062-763 | ORAL | 10 mg in 30 mL | 5/19/2025 | |
| Sandoz Inc | 0781-9227 | INTRAVENOUS | 10 mg in 1 mL | 10/17/2022 | |
| Exela Phrama Sciences, LLC | 51754-4010 | INTRAVENOUS | 10 mg in 1 mL | 3/26/2021 | |
| Physicians Total Care, Inc. | 54868-0263 | ORAL | 5 mg in 5 mL | 12/9/2011 | |
| Sincerus Florida, LLC | 72934-5071 | TOPICAL | 1 g in 100 g | 5/10/2019 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
Authorised | 7/28/2015 |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| MAXIGESIC PE FILM-COATED TABLET | SIN16703P | TABLET, FILM COATED | 2.50mg | 2/21/2023 | |
| MINIMS PHENYLEPHRINE HYDROCHLORIDE EYE DROPS 10% w/v | SIN04319P | SOLUTION | 10% w/v | 4/20/1990 | |
| Panadol FluMax Caplets | GlaxoSmithKline Dungarvan Ltd, SmithKline Beecham, S.A (Primary and Secondary Packager) | SIN13452P | TABLET, FILM COATED | 5 mg | 5/9/2008 |
| UNIFLU COLDS & FLU TABLETS | SIN07102P | TABLET | 5 mg | 7/7/1992 | |
| PHENYLALPHA SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 50MCG/ML | SIN15668P | INJECTION, SOLUTION | 50.0mcg/ml | 4/15/2019 | |
| DECOLGEN COLD & FLU EXTRA STRENGTH CAPLET | SIN12260P | TABLET | 10 mg | 4/25/2003 | |
| PHENYLALPHA SOLUTION FOR INJECTION 50mcg/ml | SIN15896P | INJECTION, SOLUTION | 50mcg/ml | 3/3/2020 | |
| SUNFLU TABLET | SIN03038P | TABLET | 5 mg | 6/7/1989 | |
| Panadol Cold Relief PE Caplet | Aspen Pharma Pty Ltd. | SIN13878P | TABLET | 5 mg | 10/27/2010 |
| MINIMS PHENYLEPHRINE HYDROCHLORIDE EYE DROPS 2.5% w/v | SIN10139P | SOLUTION | 2.5% w/v | 10/2/1998 |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| RHINO-COMFORT TAB | N/A | N/A | N/A | 11/21/2001 | |
| SURE-RELIEF COLD AND COUGH CAP | N/A | N/A | N/A | 6/30/2000 | |
| FAST FLU TAB | N/A | N/A | N/A | 10/18/2002 | |
| NEW-PRITMIN TAB | N/A | N/A | N/A | 7/9/2010 | |
| NASAL COM TAB | N/A | N/A | N/A | 11/21/2001 | |
| ANTI-COLD TAB | N/A | N/A | N/A | 9/30/2002 | |
| COFENZA CAP | N/A | N/A | N/A | 6/30/2000 | |
| PANADOL COLD & FLU HOT REMEDY POWDER | N/A | N/A | N/A | 9/5/1998 | |
| THROUGH TAB | N/A | N/A | N/A | 11/21/2001 | |
| N2012 CAP | N/A | karen laboratories o/b karen pharmaceutical co ltd | N/A | N/A | 2/8/2010 |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| DEMAZIN COLD + FLU RELIEF tablet blister pack | 286271 | Medicine | A | 3/1/2017 | |
| AVALLON COLD & FLU DAY + NIGHT RELIEF PE tablet blister pack | 300169 | Medicine | A | 3/1/2018 | |
| CHEMISTS' OWN CHILDREN'S COLD AND ALLERGY RELIEF LIQUID 6 YEARS TO ADULT oral liquid bottle | 71041 | Medicine | A | 9/14/1999 | |
| TRUST FOR KIDS DECONGESTANT & ANTIHISTAMINE ELIXIR oral liquid - solution bottle | 214691 | Medicine | A | 9/17/2013 | |
| DEMAZIN KIDS 6+ COLD RELIEF BLUE SYRUP bottle | 18813 | Medicine | A | 10/8/1991 | |
| TERRY WHITE CHEMISTS SINUS PLUS PE DUAL ACTION tablet blister pack | 199056 | Medicine | A | 7/4/2012 | |
| MEDIX SINUS + PAIN RELIEF PE tablet blister pack | 195426 | Medicine | A | 3/8/2012 | |
| MEDREICH PHENYLEPHRINE HYDROCHLORIDE 10 mg TABLETS blister pack | 175337 | Medicine | A | 9/2/2010 | |
| TERRYWHITE CHEMMART COLD & FLU RELIEF PE tablet blister pack | 295508 | Medicine | A | 10/25/2017 | |
| BLOOMS THE CHEMIST PE DAY + NIGHT COLD & FLU RELIEF tablet blister pack | 294345 | Medicine | A | 9/26/2017 |
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| PULMORPHAN | laboratoire riva inc. | 00513741 | Syrup - Oral | 3.75 MG / 5 ML | 12/31/1978 |
| DM COUGH AND COLD SYRUP | 02266466 | Syrup - Oral | 5 MG / 5 ML | 12/18/2006 | |
| DM COUGH AND COLD LIQUID | tanta pharmaceuticals inc | 02267446 | Solution - Oral | 5.0 MG / 5 ML | 2/20/2007 |
| SUDAFED PE COLD AND COUGH | mcneil consumer healthcare division of johnson & johnson inc | 02274493 | Tablet - Oral | 5 MG | N/A |
| FORMULATION R HEMORRHOIDAL OINTMENT | g&w laboratories inc. | 02246389 | Ointment - Topical | 0.25 % | N/A |
| NYQUIL COMPLETE | procter & gamble inc | 02503549 | Syrup - Oral | 10 MG / 30 ML | 7/19/2021 |
| FLU MULTI SYMPTOM RELIEF | vita health products inc | 02404818 | Kit
,
Tablet - Oral | 5 MG | N/A |
| ODAN-VERNACON | odan laboratories ltd | 00626643 | Solution - Ophthalmic | 0.125 % | 12/31/1986 |
| EXTRA STRENGTH COLD SYRUP | 02266199 | Syrup - Oral | 10 MG / 5 ML | 12/18/2006 | |
| BENYLIN DM-D SOFT CHEWS WITH MENTHACTIN | mcneil consumer healthcare division of johnson & johnson inc | 02301415 | Piece (Chewable) - Oral | 5 MG | N/A |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| CINFACOLD 1000 mg / 10 mg POLVO ORAL | Laboratorios Cinfa S.A. | 69931 | POLVO ORAL | Medicamento Sujeto A Prescripción Médica | Not Commercialized |
| PHARMAGRIP DUO 650 mg/8,2 mg POLVO ORAL | Laboratorios Cinfa S.A. | 69932 | POLVO ORAL | Sin Receta | Not Commercialized |
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.